Thrombolytic Therapy [topp]
Substrate [mnob]
acute [tmco]
Myocardial Infarction [dsyn]
Study [mnob]
Signal [phpr]
Average [qnco]
Electrocardiogram [fndg]
Endocardial [tisu]
Catheter [medd]
Mapping [acty]
ventricular [bpoc]
Stimulation [topp]
Thrombolytic Therapy [topp]
Survival [acty]
Acute myocardial infarction [dsyn]
Preserving [ftcn]
Left Ventricular Function [ortf]
influential [idcn]
Substrate [mnob]
Uncertain [idcn]
investigate [ftcn]
Electrophysiology [bmod]
effects [qlco]
Thrombolytic Therapy [topp]
Signal-averaged electrocardiography [diap]
Endocardial [tisu]
Catheter [medd]
Mapping [acty]
Stimulation [topp]
Performed [ftcn]
Consecutive [qlco]
Patients [podg]
First myocardial infarction [dsyn]
acute [tmco]
Thrombolytic Therapy [topp]
Reperfusion [topp]
Patients [podg]
Group 1 [inpr]
Patients [podg]
Group 2 [inpr]
Signal [phpr]
Average [qnco]
Electrocardiogram abnormal [fndg]
Group 1 [inpr]
Patients [podg]
Group 2 [inpr]
Patients [podg]
P NOS [aapp, imft]
Catheter [medd]
Mapping [acty]
Detected [fndg]
Delayed [tmco]
Endocardial [tisu]
Group 1 [inpr]
Patients [podg]
Group 2 [inpr]
Patients [podg]
Spatial Distribution [spco]
Smaller [qlco]
Long duration [qlco]
Endocardial [tisu]
short [qlco]
Group I [inpr]
Group 2 [inpr]
P NOS [aapp, imft]
Sustained ventricular tachycardia [dsyn]
Induced [ftcn]
Group 1 [inpr]
Group 2 [inpr]
P NOS [aapp, imft]
Thrombolytic Therapy [topp]
Substrate [mnob]
Electrical [npop]
Stability [qlco]
Acute myocardial infarction [dsyn]
Anti-arrhythmic [phsu]
Contribute [acty]
Part [spco]
Improved [qlco]
Survival [acty]
Patients [podg]
treated [topp]
Thrombolytic Drugs [phsu]
